Antihypertensive and noradrenaline-depleting effects of guanethidine metabolites.
D018663:Adrenergic Agents / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002417:Cattle; D003497:Cyclic N-Oxides / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000378:metabolism; D006145:Guanethidine / Q000378:metabolism* / Q000494:pharmacology*; D006146:Guanidines / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D013154:Spleen / Q000294:innervation; D014316:Tritium
D018663:Adrenergic Agents; D003497:Cyclic N-Oxides; D006146:Guanidines; D007093:Imidazoles; D014316:Tritium; D009638:Norepinephrine; D006145:Guanethidine